Literature DB >> 10741748

Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma.

K Yamashita1, M Mori, T Shiraishi, K Shibuta, K Sugimachi.   

Abstract

Matrix metalloproteinase-7 (MMP-7) is a member of MMP family and has a wide variety of substrate spectra. It is reported to play an important role in carcinoma invasion and metastasis. There is, however, little information on the clinical significance of MMP-7 in human esophageal carcinoma. We thus studied 48 tumor/normal pair samples of human esophagus by Northern blot analysis. The results demonstrated that the tumor tissue (T) of esophageal carcinoma showed a higher expression of MMP-7 mRNA than the corresponding normal tissue (N) in 31 cases (65%). We also statistically evaluated tumor MMP-7 value (T value) corrected for MMP-7-positive control (KYSE150 transfected with the MMP-7 gene). Fourteen cases with T value > or = 0.3 showed a higher frequency of lymph node metastasis than 34 cases with T value < 0.3 (P < 0.05). The cases with T value > or = 0.3 showed a significantly poorer prognosis than those with T value < 0.3 (P < 0.01). Multivariate analysis demonstrated that the MMP-7 expression status was the independent factor relating to the prognosis (P = 0.0005). The findings indicated that MMP-7 might be a novel prognostic factor for patients with esophageal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10741748

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  22 in total

1.  Effects of Weipixiao (胃痞消) on Wnt pathway-associated proteins in gastric mucosal epithelial cells from rats with gastric precancerous lesions.

Authors:  Jin-hao Zeng; Hua-feng Pan; You-zhang Liu; Hai-bo Xu; Zi-ming Zhao; Hai-wen Li; Jin-ling Ren; Long-hui Chen; Xia Hu; Yan Yan
Journal:  Chin J Integr Med       Date:  2015-04-14       Impact factor: 1.978

2.  Gene expression profile changes correlated with lymph node metastasis in oral squamous cell carcinoma.

Authors:  Haruhiko Kashiwazaki; Nur Mohammad Monsur Hassan; Jun-Ichi Hamada; Tetsuya Moriuchi; Yutaka Yamazaki; Kanchu Tei; Yasunori Totsuka; Nobuo Inoue
Journal:  Odontology       Date:  2008-07-27       Impact factor: 2.634

3.  Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis.

Authors:  Laszlo Herszenyi; Istvan Hritz; Istvan Pregun; Ferenc Sipos; Mark Juhasz; Bela Molnar; Zsolt Tulassay
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

4.  Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer.

Authors:  Alexandra Mj Langers; Hein W Verspaget; Daniel W Hommes; Cornelis Fm Sier
Journal:  World J Gastrointest Oncol       Date:  2011-06-15

5.  Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer.

Authors:  Yonggang Liang; Shanxian Guo; Qinghua Zhou
Journal:  Tumour Biol       Date:  2013-12-14

6.  Identification of molecular markers for metastasis-related genes in primary breast cancer cells.

Authors:  Koshi Mimori; Akemi Kataoka; Keiji Yoshinaga; Mitsuhiko Ohta; Yasuaki Sagara; Yasuji Yoshikawa; Shinji Ohno; Graham F Barnard; Masaki Mori
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

7.  High expression of matrix metalloproteinase-9 indicates poor prognosis in human hilar cholangiocarcinoma.

Authors:  Qi Sun; Chuanzong Zhao; Leizhou Xia; Zhaobin He; Zhihua Lu; Chuan Liu; Ming Jia; Jiayong Wang; Jun Niu
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

8.  Sensitive surface enhanced Raman scattering multiplexed detection of matrix metalloproteinase 2 and 7 cancer markers.

Authors:  Tianxun Gong; Kien Voon Kong; Douglas Goh; Malini Olivo; Ken-Tye Yong
Journal:  Biomed Opt Express       Date:  2015-05-12       Impact factor: 3.732

9.  Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximab.

Authors:  Xabier Garcia-Albeniz; Carles Pericay; Virginia Alonso-Espinaco; Vicente Alonso; Pilar Escudero; Carlos Fernández-Martos; Rosa Gallego; Pere Gascón; Sergi Castellví-Bel; Joan Maurel
Journal:  Tumour Biol       Date:  2010-11-23

10.  Correlation among 16 biological factors [p53, p21(waf1), MIB-1 (Ki-67), p16(INK4A), cyclin D1, E-cadherin, Bcl-2, TNF-α, NF-κB, TGF-β, MMP-7, COX-2, EGFR, HER2/neu, ER, and HIF-1α] and clinical outcomes following curative chemoradiation therapy in 10 patients with esophageal squamous cell carcinoma.

Authors:  Shino Shibata-Kobayashi; Hideomi Yamashita; Kae Okuma; Kenshiro Shiraishi; Hiroshi Igaki; Kuni Ohtomo; Keiichi Nakagawa
Journal:  Oncol Lett       Date:  2013-01-11       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.